Director's Dealing • Jan 29, 2024
Director's Dealing
Open in ViewerOpens in native device viewer
January 29, 2024 Company announcement No. 04
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Novo Holdings A/S | ||
| 2. | Reason for the notification | |||
| a) | Position/status | Novo Holdings A/S is closely related to its CEO Kasim Kutay, who is a member of Novozymes A/S' board of directors. |
||
| b) | Initial notification/ Amendment |
Initial notification | ||
| 3. | auction monitor | Details of the issuer, emission allowance market participant, auction platform, auctioneer or | ||
| a) | Name | Novozymes A/S | ||
| b) | LEI | 529900T6WNZXD2R3JW38 | ||
| 4. | conducted | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been |
||
| a) | Description of the financial instrument, type of instrument |
B-Shares | ||
| Identification code | DK0060336014 | |||
| b) | Nature of the transaction | Exchange of shares in Novozymes A/S in connection with merger between Novozymes A/S and Chr. Hansen Holding A/S |
||
| c) | Price(s) and volume(s) | Price(s) 28,983,112 shares in Chr. Hansen Holding A/S |
Volume(s) 29,641,028 shares |
|
| d) | Aggregated information - Aggregated volume - Price |
|||
| e) | Date of transaction | 29 January 2024 | ||
| f) | Place of the transaction | Outside a trading venue |
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Krogshoejvej 36 2880 Bagsvaerd Denmark
Phone: +45 4446 0000
Trading by management and close relations of management. Company announcement No. 04
| Contact information | ||
|---|---|---|
| Investor Relations | ||
| Tobias Bjorklund | +45 3077 8682 | [email protected] |
| Anders Enevoldsen | +45 5350 1453 | [email protected] |
| Media Relations | ||
| Lina Danstrup | +45 3077 0552 | [email protected] |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.